| Year |
Title |
Altmetric |
| 2019
|
The apoA-I mimetic peptide 4F protects apolipoprotein A-I from oxidative damage
2019
|
|
| 2018
|
Novel fatty acyl apoE mimetic peptides have increased potency to reduce plasma cholesterol in mice and macaques
2018
|
|
| 2018
|
The apolipoprotein e mimetic peptide AEM-2 attenuates mitochondrial injury and apoptosis in human THP-1 macrophages
2018
|
|
| 2017
|
Cholesterol reduction and macrophage function: Role of paraoxonases
2017
|
|
| 2017
|
High-density lipoprotein regulation of mitochondrial function
2017
|
|
| 2016
|
Apolipoprotein mimetic peptides as modulators of lipoprotein function
2016
|
|
| 2016
|
High-density lipoprotein, mitochondrial dysfunction and cell survival mechanisms
2016
|
|
| 2016
|
Independent effects of early-life experience and trait aggression on cardiovascular function
2016
|
|
| 2015
|
Recent developments in modulating atherogenic lipoproteins
2015
|
|
| 2015
|
Bioenergetic programming of macrophages by the apolipoprotein A-I mimetic peptide 4F
2015
|
|
| 2015
|
Early changes in vascular reactivity in response to 56Fe irradiation in ApoE-/- mice
2015
|
|
| 2014
|
Anti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: A review
2014
|
|
| 2014
|
Inhibitors of arachidonate-regulated calcium channel signaling suppress triggered activity induced by the late sodium current
2014
|
|
| 2014
|
L-4F Inhibits Lipopolysaccharide-Mediated Activation of Primary Human Neutrophils
2014
|
|
| 2013
|
Anti-Inflammatory Mechanisms of Apolipoprotein A-I Mimetic Peptide in Acute Respiratory Distress Syndrome Secondary to Sepsis
2013
|
|
| 2012
|
Regulation of pattern recognition receptors by the apolipoprotein A-I mimetic peptide 4F
2012
|
|
| 2012
|
Preservation of biological function despite oxidative modification of the apolipoprotein A-I mimetic peptide 4F
2012
|
|
| 2011
|
HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats.
2011
|
|
| 2011
|
Acyloxy nitroso compounds as nitroxyl (HNO) donors: Kinetics, reactions with thiols, and vasodilation properties
2011
|
|
| 2010
|
ApoE mimetic peptide reduces plasma lipid hydroperoxide content with a concomitant increase in HDL paraoxonase activity
2010
|
|
| 2010
|
The apolipoprotein A-I mimetic peptide 4F prevents defects in vascular function in endotoxemic rats
2010
|
|
| 2010
|
Dietary flavonoid quercetin stimulates vasorelaxation in aortic vessels
2010
|
|
| 2010
|
Potential for chlorine gas-induced injury in the extrapulmonary vasculature
2010
|
|
| 2010
|
Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages
2010
|
|
| 2010
|
Anti-inflammatory and recycling properties of an apolipoprotein mimetic peptide, Ac-hE18A-NH2
2010
|
|
| 2009
|
Apolipoprotein A-I mimetic peptide treatment inhibits inflammatory responses and improves survival in septic rats
2009
|
|
| 2009
|
Pulmonary ozone exposure induces vascular dysfunction, mitochondrial damage, and atherogenesis
2009
|
|
| 2009
|
Protein O-GlcNAcylation: A new signaling paradigm for the cardiovascular system
2009
|
|
| 2009
|
Vasculoprotective Effects of Apolipoprotein Mimetic Peptides: An Evolving Paradigm In Hdl Therapy (Vascular Disease Prevention, In Press.).
2009
|
|
| 2008
|
HDL therapy for cardiovascular diseases: The road to HDL mimetics
2008
|
|
| 2006
|
Atherosclerosis and vascular disease: Effects of peptide mimetics of apolilpoproteins
2006
|
|
| 2006
|
Synthetic peptides: Managing lipid disorders
2006
|
|
| 2005
|
Antihypertensive and cognitive effects of grape polyphenols in estrogen-depleted, female, spontaneously hypertensive rats
2005
|
|
| 2005
|
Evidence of cardiovascular protection by moderate alcohol: Role of nitric oxide
2005
|
|
| 2005
|
Inhibition of lipopolysaccharide-induced inflammatory responses by an apolipoprotein AI mimetic peptide
2005
|
|
| 2005
|
Apolipoprotein E mimetic peptide dramatically lowers plasma cholesterol and restores endothelial function in Watanabe heritable hyperlipidemic rabbits
2005
|
|
| 2005
|
Assessing NO-dependent vasodilatation using vessel bioassays at defined oxygen tensions
2005
|
|
| 2004
|
L-Arginine inhibits xanthine oxidase-dependent endothelial dysfunction in hypercholesterolemia
2004
|
|
| 2003
|
Vasoactivity of S-nitrosohemoglobin: Role of oxygen, heme, and NO oxidation states
2003
|
|
| 2003
|
The neointimal response ot endovascular injury is increased in obese Zucker rats
2003
|
|
| 2002
|
Nitrolinoleate, a nitric oxide-derived mediator of cell function: Synthesis, characterization, and vasomotor activity
2002
|
|
| 2002
|
Myeloperoxidase, a leukocyte-derived vascular NO oxidase
2002
|
|
| 2001
|
Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease
2001
|
|
| 2001
|
Endothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitration.
2001
|
|
| 2001
|
Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid
2001
|
|
| 2001
|
Endothelial dysfunction is induced by proinflammatory oxidant hypochlorous acid.
2001
|
|
| 2001
|
L-Arginine Chlorination Products Inhibit Endothelial Nitric Oxide Production
2001
|
|
| 2001
|
Enhanced antioxidant activity after chlorination of quercetin by hypochlorous acid
2001
|
|
| 2001
|
Formation of novel bioactive metabolites from the reactions of pro-inflammatory oxidants with polyphenolics
2001
|
|
| 2001
|
Human angiotensin II type 1 receptor isoforms encoded by messenger RNA splice variants are functionally distinct
2001
|
|
| 2000
|
Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats.
2000
|
|
| 1999
|
Chemiluminescent detection of oxidants in vascular tissue: Lucigenin but not coelenterazine enhances superoxide formation
1999
|
|
| 1999
|
Biological aspects of reactive nitrogen species
1999
|
|
| 1999
|
Nitric oxide donor generation from reactions of peroxynitrite
1999
|
|
| 1998
|
Nitrosation of uric acid by peroxynitrite: Formation of a vasoactive nitric oxide donor
1998
|
|
| 1998
|
Captopril treatment and its withdrawal prevents impairment of endothelium-dependent responses in the spontaneously hypertensive rat
1998
|
|
| 1997
|
No role for NO in estrogen-mediated vasoprotection?
1997
|
|
| 1997
|
Formation of the NO donors glyceryl mononitrate and glyceryl mononitrite from the reaction of peroxynitrite with glycerol
1997
|
|
| 1997
|
Estrogen restores endothelial cell function in an experimental model of vascular injury
1997
|
|
| 1997
|
Immunoglobulin light chain alters mesangial cell calcium homeostasis
1997
|
|
| 1997
|
Immunoglobulin light chain alters mesangial cell calcium homeostasis.
1997
|
|
| 1997
|
Gender and cardiovascular disease: Recent insights
1997
|
|
| 1997
|
Nitric oxide, free radicals and cell signalling in cardiovascular disease
1997
|
|
| 1997
|
The interplay of nitric oxide and peroxynitrite with signal transduction pathways: Implications for disease
1997
|
|
| 1996
|
Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits
1996
|
|
| 1995
|
A functional comparison of the rat type-1 angiotensin II receptors (AT1AR and AT1BR)
1995
|
|
| 1995
|
Hyperglycemia alters cytoplasmic Ca2+ responses to capacitative Ca2+ influx in rat aortic smooth muscle cells
1995
|
|
| 1995
|
Calcium-Sensitive Chloride Channels in Vascular Smooth Muscle Cells
1995
|
|
| 1995
|
Oxygen Radical-Nitric Oxide Reactions in Vascular Diseases
1995
|
|
| 1994
|
Calcium-mobilizing agonists stimulate anion fluxes in cultured endothelial cells from human umbilical vein
1994
|
|
| 1994
|
Superoxide and peroxynitrite in atherosclerosis
1994
|
|
| 1994
|
Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry.
1994
|
|
